retatrutide trial weight loss data New retatrutide Phase 3 data dropped and everyone's running with the big number. 30% body weight loss at 12mg. Impressive headline. But nobody's talking about 4mg. 📊 19% body weight loss 📊

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders Fierce Pharma A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes GLP 1 medications can reduce appetite significantly but nutrition still matters deeply. When eating less, prioritising: Protein helps preserve muscle Fiber supports digestion, fullness & gut health Weight loss should New GLP 3 drug significantly slashes both weight and blood sugar levels in Phase III trial Creatine for GLP 1 Users: Science Backed Strategy to Prevent Muscle Loss and Skinny Fat Doctor Comment: Eli Lilly Drug Retatrutide Clinical Trial Results